Evaluation of the Quality of Life of Patients With DBB With the Installation of OPEP

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06820983

Acronym

EQOPEP

Enrollment

Registered

2025-02-11

Start date

2024-10-17

Completion date

2026-04-01

Last updated

2026-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis, Physiotherapy, Quality of Life

Keywords

quality of life, Bronchiectasis, oscillating PEP devices, physiotherapy

Brief summary

To carry out an assessment of compliance and quality of life in a population (children and adults) with DDB before and after the use of an oscillating PEP. The aim is to determine the impact of the use of oscillating PEP on the daily life of this population in particular.

Interventions

OTHERadult questionnary for parents of children aged 8 to 13

Quality of life questionnaire for parents of children aged 8 to 13

OTHERQuality of life questionnaire for children aged 8 to 13

Quality of life questionnaire for children aged 8 to 13

OTHERQuality of life questionnaire for adolescents aged 14 to 17

Quality of life questionnaire for adolescents aged 14 to 17

OTHERQuality of life questionnaire for adults

Quality of life questionnaire for adults

OTHERA satisfaction adherence questionnaire

A satisfaction adherence questionnaire will also be distributed to patients after several months' use of oscillating PEP

Study design

Allocation

Intervention model

PARALLEL

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

8 Years to No maximum

Healthy volunteers

Inclusion criteria

* Children (from 8 years of age) and adults over 18 years of age with DDB who doesn't use oscillating PEP. The study population will be clinically stable and will be seen in follow-up consultations.

Exclusion criteria

* Children under 8 years of age. * Patients who use an OPEP * Patients in the acute exacerbation phase of their DDB * Patients who are not under regular consultation * Patients with severe, uncontrolled co-morbidities * Patients with cognitive or psychiatric disorders preventing proper adherence to the study protocol * Patients taking part simultaneously in another clinical study that could interfere with the results of the OPEP study

Design outcomes

Primary

Measure	Time frame	Description
Variation of patient quality of life before and after OPEP installation	18 months	quality of life is determined by qustionnaire

Countries

France

Contacts

CONTACTThomas PINTO, MD

pinto.thomas@chu-amiens.fr33+3 22 08 80 00

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026